Erratum: A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis

Alejandro Arroliga; Robert Balk; Chad Cannon; Nathan Dean; Phillip Dellinger; Paula Dennen; Juan Figueroa; Eugene Fletcher; Kalpalatha K. Guntupalli; David T. Huang; Mitchell Levy; Takkin Lo; Imrana Malik; Benjamin Margolis; George Matuschak; Laura Moore; Gregory J. Moran; Eugene Moretti; Peter Morris; Edward A Panacek; Emanual Rivers; Greg Schmidt; Michael G. Seneff; Jay Steingrub; Robert Taylor

doi:10.1097/CCM.0000000000000348

Erratum: A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis

Alejandro Arroliga, Robert Balk, Chad Cannon, Nathan Dean, Phillip Dellinger, Paula Dennen, Juan Figueroa, Eugene Fletcher, Kalpalatha K. Guntupalli, David T. Huang, Mitchell Levy, Takkin Lo, Imrana Malik, Benjamin Margolis, George Matuschak, Laura Moore, Gregory J. Moran, Eugene Moretti, Peter Morris, Edward A PanacekEmanual Rivers, Greg Schmidt, Michael G. Seneff, Jay Steingrub, Robert Taylor

Emergency Medicine

Research output: Contribution to journal › Article

Original language	English (US)
Journal	Critical Care Medicine
Volume	42
Issue number	5
DOIs	https://doi.org/10.1097/CCM.0000000000000348
State	Published - 2014

ASJC Scopus subject areas

Critical Care and Intensive Care Medicine

Access to Document

10.1097/CCM.0000000000000348

Cite this

Arroliga, A., Balk, R., Cannon, C., Dean, N., Dellinger, P., Dennen, P., Figueroa, J., Fletcher, E., Guntupalli, K. K., Huang, D. T., Levy, M., Lo, T., Malik, I., Margolis, B., Matuschak, G., Moore, L., Moran, G. J., Moretti, E., Morris, P., ... Taylor, R. (2014). Erratum: A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis. Critical Care Medicine, 42(5). https://doi.org/10.1097/CCM.0000000000000348

Erratum : A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis. / Arroliga, Alejandro; Balk, Robert; Cannon, Chad; Dean, Nathan; Dellinger, Phillip; Dennen, Paula; Figueroa, Juan; Fletcher, Eugene; Guntupalli, Kalpalatha K.; Huang, David T.; Levy, Mitchell; Lo, Takkin; Malik, Imrana; Margolis, Benjamin; Matuschak, George; Moore, Laura; Moran, Gregory J.; Moretti, Eugene; Morris, Peter; Panacek, Edward A; Rivers, Emanual; Schmidt, Greg; Seneff, Michael G.; Steingrub, Jay; Taylor, Robert.

In: Critical Care Medicine, Vol. 42, No. 5, 2014.

Research output: Contribution to journal › Article

Arroliga, A, Balk, R, Cannon, C, Dean, N, Dellinger, P, Dennen, P, Figueroa, J, Fletcher, E, Guntupalli, KK, Huang, DT, Levy, M, Lo, T, Malik, I, Margolis, B, Matuschak, G, Moore, L, Moran, GJ, Moretti, E, Morris, P, Panacek, EA, Rivers, E, Schmidt, G, Seneff, MG, Steingrub, J & Taylor, R 2014, 'Erratum: A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis', Critical Care Medicine, vol. 42, no. 5. https://doi.org/10.1097/CCM.0000000000000348

Arroliga, Alejandro ; Balk, Robert ; Cannon, Chad ; Dean, Nathan ; Dellinger, Phillip ; Dennen, Paula ; Figueroa, Juan ; Fletcher, Eugene ; Guntupalli, Kalpalatha K. ; Huang, David T. ; Levy, Mitchell ; Lo, Takkin ; Malik, Imrana ; Margolis, Benjamin ; Matuschak, George ; Moore, Laura ; Moran, Gregory J. ; Moretti, Eugene ; Morris, Peter ; Panacek, Edward A ; Rivers, Emanual ; Schmidt, Greg ; Seneff, Michael G. ; Steingrub, Jay ; Taylor, Robert. / Erratum : A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis. In: Critical Care Medicine. 2014 ; Vol. 42, No. 5.

@article{a0b7fbaa97404009866a7c4ad33c809f,

title = "Erratum: A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis",

author = "Alejandro Arroliga and Robert Balk and Chad Cannon and Nathan Dean and Phillip Dellinger and Paula Dennen and Juan Figueroa and Eugene Fletcher and Guntupalli, {Kalpalatha K.} and Huang, {David T.} and Mitchell Levy and Takkin Lo and Imrana Malik and Benjamin Margolis and George Matuschak and Laura Moore and Moran, {Gregory J.} and Eugene Moretti and Peter Morris and Panacek, {Edward A} and Emanual Rivers and Greg Schmidt and Seneff, {Michael G.} and Jay Steingrub and Robert Taylor",

year = "2014",

doi = "10.1097/CCM.0000000000000348",

language = "English (US)",

volume = "42",

journal = "Critical Care Medicine",

issn = "0090-3493",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Erratum

T2 - A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis

AU - Arroliga, Alejandro

AU - Balk, Robert

AU - Cannon, Chad

AU - Dean, Nathan

AU - Dellinger, Phillip

AU - Dennen, Paula

AU - Figueroa, Juan

AU - Fletcher, Eugene

AU - Guntupalli, Kalpalatha K.

AU - Huang, David T.

AU - Levy, Mitchell

AU - Lo, Takkin

AU - Malik, Imrana

AU - Margolis, Benjamin

AU - Matuschak, George

AU - Moore, Laura

AU - Moran, Gregory J.

AU - Moretti, Eugene

AU - Morris, Peter

AU - Panacek, Edward A

AU - Rivers, Emanual

AU - Schmidt, Greg

AU - Seneff, Michael G.

AU - Steingrub, Jay

AU - Taylor, Robert

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84899486244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899486244&partnerID=8YFLogxK

U2 - 10.1097/CCM.0000000000000348

DO - 10.1097/CCM.0000000000000348

M3 - Article

AN - SCOPUS:84899486244

VL - 42

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 5

ER -